Quraishi, M.N. et al. Journal of Hospital Infection.Published online: November 3 2016
We read with interest the recent editorial on faecal microbiota transplantation for recurrent or refractory Clostridium difficile infection (CDI) in which Dr Goldberg summarizes the efficacy of this treatment but also the obstacles in the way of undertaking this treatment.1 Indeed although the National Institute of Health and Care Excellence advocate the use of faecal microbiota transplantation (FMT) for recurrent or refractory Clostridium difficile infection (CDI) when antibiotics fail, our perception is that it has not been widely adopted in the UK.
Read the abstract here